{"id":781362,"date":"2023-08-31T10:00:39","date_gmt":"2023-08-31T14:00:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/"},"modified":"2023-08-31T10:00:39","modified_gmt":"2023-08-31T14:00:39","slug":"third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/","title":{"rendered":"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN FRANCISCO, Aug.  31, 2023  (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET.<\/p>\n<p>A live audio webcast will be available within the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uTY6-jErc5UbAwnrnhc5gIlwA4WMr-5i7nluiUXMAmZmSoUIsM3NMbfvzewIHYUWwQWVi3MUBPTRuYettxWbPyuLykhc2mfhKaP8ym9VhhTMqK5qOhjRA_BCLjyqDQAP2E-vKhLUNW29Ov2fmjpygQ==\" rel=\"nofollow noopener\" target=\"_blank\">Investors and Media<\/a>\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event.<\/p>\n<p>\n        <strong>About Third Harmonic Bio, Inc.<\/strong><br \/>\n        <br \/>Third Harmonic Bio is a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases through the development of novel highly selective, oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Early clinical studies demonstrate that KIT inhibition has the potential to revolutionize the treatment of a broad range of mast-cell-mediated inflammatory diseases, and that a titratable, oral, intracellular small molecule inhibitor may provide the optimal therapeutic profile against this target. Third Harmonic\u2019s lead product candidate THB335 is expected to enter clinical trials during the first half of 2024. For more information, please visit the Third Harmonic Bio website:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WjIDAiNcpeJCMYOo5mFKVEiKX_QIjRSjKgzHLw4myQlP1iPYIhy9YQcXdlIFUt46Af_q56q3BiopHq0DHzo6L_4hbdekNanLUEy4KQnFhvk=\" rel=\"nofollow noopener\" target=\"_blank\">www.thirdharmonicbio.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Bob Ho<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ta4_Zfro37J3wmvXtgRg9QSpJ3BfmZB5Ff-J3YMGxqYO3AKnGc2SvKWhTFkPwG86TC9PmljtPRW-cLoKkaRqhyHaUJ1RLtXR__v5tSHNwguX9_Pw8mJ-dPjziquPsX27Y0dqqSXuYVMXgNONndH9HvIHtsSMp_21t4rUZXlMFyQF8Idfm60RReDaAjm56Fyi-3YuWE5Ymaymjlx6ynYJ6ZlotPki5euw5La6hzix6ZmNlBQgQ9nOSbfS6tce6FZ4zEROybThqC10et4JTihvHQ==\" rel=\"nofollow noopener\" target=\"_blank\">rho@thirdharmonicbio.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NGE2OWYwZGQtM2UzMC00MmFlLWIzMzgtMzNkODdmMTNhMDUyLTEyNTgxMTk=\/tiny\/Third-Harmonic-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET. A live audio webcast will be available within the\u00a0Investors and Media\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event. About Third Harmonic Bio, Inc. Third Harmonic Bio is a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases through the development of novel highly selective, oral small-molecule inhibitors of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-781362","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET. A live audio webcast will be available within the\u00a0Investors and Media\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event. About Third Harmonic Bio, Inc. Third Harmonic Bio is a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases through the development of novel highly selective, oral small-molecule inhibitors of &hellip; Continue reading &quot;Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-31T14:00:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference\",\"datePublished\":\"2023-08-31T14:00:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/\"},\"wordCount\":226,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/\",\"name\":\"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=\",\"datePublished\":\"2023-08-31T14:00:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Market Newsdesk","og_description":"SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) &#8212; Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET. A live audio webcast will be available within the\u00a0Investors and Media\u00a0section of the\u00a0Third Harmonic Bio website. An archived replay will be accessible for 90 days following the event. About Third Harmonic Bio, Inc. Third Harmonic Bio is a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases through the development of novel highly selective, oral small-molecule inhibitors of &hellip; Continue reading \"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-31T14:00:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference","datePublished":"2023-08-31T14:00:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/"},"wordCount":226,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/","name":"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=","datePublished":"2023-08-31T14:00:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzk1NyM1NzkxNDQxIzIyNDY1NjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/third-harmonic-bio-to-participate-in-the-morgan-stanley-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781362","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=781362"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/781362\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=781362"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=781362"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=781362"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}